KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Net Margin: 2018-2025

Historic Net Margin for BioNTech SE (BNTX) over the last 7 years, with Sep 2025 value amounting to 5.14%.

  • BioNTech SE's Net Margin fell 444.00% to 5.14% in Q3 2025 from the same period last year, while for Sep 2025 it was -14.60%, marking a year-over-year decrease of 918.00%. This contributed to the annual value of -24.18% for FY2024, which is 4854.00% down from last year.
  • Per BioNTech SE's latest filing, its Net Margin stood at 5.14% for Q3 2025, which was up 103.20% from -160.58% recorded in Q2 2025.
  • Over the past 5 years, BioNTech SE's Net Margin peaked at 117.07% during Q3 2021, and registered a low of -624.55% during Q2 2024.
  • Its 3-year average for Net Margin is -127.47%, with a median of 5.14% in 2025.
  • In the last 5 years, BioNTech SE's Net Margin slumped by 47,086bps in 2023 and then skyrocketed by 46,397bps in 2025.
  • Over the past 5 years, BioNTech SE's Net Margin (Quarterly) stood at 0.00% in 2021, then spiked by 9,505bps to 95.05% in 2022, then tumbled by 3,633bps to 58.72% in 2023, then crashed by 2,991bps to 28.82% in 2024, then tumbled by 444bps to 5.14% in 2025.
  • Its Net Margin stands at 5.14% for Q3 2025, versus -160.58% for Q2 2025 and -259.85% for Q1 2025.